WATERTOWN, Mass.--(BUSINESS WIRE)--Nov. 23, 2005--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Lazard Capital Markets Annual Life Sciences Conference to be held at the New York Palace hotel in New York, NY on November 29-30. Panacos' presentation is scheduled to begin on November 30 at 3:30 p.m., Eastern Standard Time. Dr. Samuel K. Ackerman, President and CEO of Panacos, will present.